Plasma p-tau181 accurately predicts Alzheimer’s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline - Lantero Rodriguez, J; Karikari, T K; Suárez-Calvet, M (Acta Neuropathol, 2020)
et al.